David M Mott

Director

David M Mott (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Ardelyx, Inc. (ARDX). Across 1 priced purchase filing, the average 21-session return was -18.2% from execution and -6.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.9M of ARDX (333,333 sh × $5.84, as filed), executed Feb 20.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-18.2%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

-6.2%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.9M

shares × price, as filed

Last traded

Feb 20

Filed Feb 23

Median ADV $16.1M across their filed names

Impact on $10,000 · 12M

$9,382 (-6.2%)

S&P 500 $11,725 (+17.2%) · 23.4 pts behind

David M Mott S&P 500

Compounded across filings from disclosure dates · past 12 months

Open performance→

Volume by month

Buys $8.7M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

ARDX

Ardelyx, Inc. ARDX · 9 buys · 0 sells 9 filings

Recent filings

ARDXPURCHASE Ardelyx, Inc. View filing → $997K
215,868 sh × $4.62
Exec Nov 13 2024
Filed Nov 14 2024 · 5:30 PM ET